rs1817567

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000441026.1(ENSG00000234172):​n.104-1274G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.178 in 150,420 control chromosomes in the GnomAD database, including 3,747 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 3747 hom., cov: 31)

Consequence

ENSG00000234172
ENST00000441026.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.69

Publications

7 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000441026.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.257 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000441026.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000234172
ENST00000441026.1
TSL:2
n.104-1274G>A
intron
N/A
ENSG00000234172
ENST00000828168.1
n.140-15773G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
26776
AN:
150312
Hom.:
3749
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0637
Gnomad AMI
AF:
0.160
Gnomad AMR
AF:
0.131
Gnomad ASJ
AF:
0.285
Gnomad EAS
AF:
0.0582
Gnomad SAS
AF:
0.159
Gnomad FIN
AF:
0.201
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.260
Gnomad OTH
AF:
0.171
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.178
AC:
26771
AN:
150420
Hom.:
3747
Cov.:
31
AF XY:
0.172
AC XY:
12633
AN XY:
73300
show subpopulations
African (AFR)
AF:
0.0636
AC:
2624
AN:
41236
American (AMR)
AF:
0.130
AC:
1972
AN:
15114
Ashkenazi Jewish (ASJ)
AF:
0.285
AC:
990
AN:
3470
East Asian (EAS)
AF:
0.0581
AC:
298
AN:
5126
South Asian (SAS)
AF:
0.159
AC:
759
AN:
4788
European-Finnish (FIN)
AF:
0.201
AC:
2003
AN:
9956
Middle Eastern (MID)
AF:
0.235
AC:
69
AN:
294
European-Non Finnish (NFE)
AF:
0.260
AC:
17557
AN:
67436
Other (OTH)
AF:
0.169
AC:
354
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
996
1993
2989
3986
4982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.215
Hom.:
7464
Bravo
AF:
0.166
Asia WGS
AF:
0.0980
AC:
339
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.26
DANN
Benign
0.52
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1817567;
hg19: chr2-184797826;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.